Testosterone in patients of erectile dysfunction with and without diabetes mellitus type 2

  • Javaid Hassan Muhammad College of Medicine, Peshawar, Pakistan.
  • Shafiq Ur Rehman Department of Physiology, Khyber Medical College, Peshawar, Pakistan
  • Inayat Shah Department of Physiology, Khyber Medical University, Peshawar, Pakistan
  • Muhammad Irfan Shereen Department of Physiology, Muhammad College of Medicine, Peshawar, Pakistan
  • Zain Ul Abideen Kohat Institute of Medical Sciences, Kohat, Pakistan
  • Henna Salman Department of Physiology, Khyber Medical College, Peshawar, Pakistan
Keywords: Testosterone, Erectile dysfunction, Diabetese, Male

Abstract

Introduction:

Testosterone administration increase rigidity and duration of erection in patients of erectile dysfunction. There is strong association of Erectile dysfunction with increasing age and decrease in the level of testosterone. The effects of deficiency of male hormones on sexual performance mainly by inhibiting the production or action of male hormones.

Objective

To find out prolactin in erectile dysfunction patients with/without Diabetes Mellitus and compare the difference in Testosterone levels of Erectile dysfunction patients across the two groups of diabetic and non-diabetic patients.

 

Methodology

A comparative cross-sectional study was conducted on 100 diabetics and 100 non-diabetic patients to assess Testosterone, both total and free was determined in patients of Erectile dysfunction with and without Diabetes Mellitus type-2. Calibrator measurements were also performed for testosterone. Independent sample t-test was performed for comparison between the two groups.

 

Results

Majority of patients were 40-49 years old (44.5%). Duration of Erectile Dysfunction was higher in Diabetic patients compared to Non-Diabetics. Free testosterone was significantly low in Diabetic group with a P value of 0.049.

 

Conclusions

There was no significant difference between the two groups in case of total testosterone.

References

Hull EM, Lorrain DS, Du J, Matuszewich L, Lumley LA, Putnam SK, et al. Hormone-neurotransmitter interactions in the control of sexual behavior. Behav Brain Res 1999;105(1):105–16.

Isidori AM, Buvat J, Corona G, Goldstein I, Jannini EA, Lenzi A, et al. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment—a systematic review. Eur Urol 2014;65(1):99–112.

Vignozzi L, Morelli A, Filippi S, Ambrosini S, Mancina R, Luconi M, et al. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. J Sex Med 2007;4(3):620–32.

Martínez‐Jabaloyas JM, Queipo‐Zaragozá A, Pastor‐Hernández F, Gil‐Salom M, Chuan‐Nuez P. Testosterone levels in men with erectile dysfunction. BJU Int 2006;97(6):1278–83.

DeFina LF, Radford NB, Leonard D, Wilson RK, Cooper TC, Clark SM, et al. Traditional signs and symptoms commonly attributed to hypogonadism do not correlate with testosterone levels: the Cooper Center Longitudinal Study Experience. J Investigative Med 2020;68(2):378–82.

Rajfer J. Relationship between testosterone and erectile dysfunction. Rev Urol 2000;2(2):122–8.

Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 2007;30(4):911–7.

Cohen P. The hypogonadal–obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt –a major factor in the genesis of morbid obesity. Med Hypotheses 1999;52(1):49–51.

Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009;6(5):1232–47.

Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. European urology. 2005;47(1):80‒6.

Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002;25(8):1458–63.

Mayans L. Metabolic syndrome: insulin resistance and prediabetes. FP Essent 2015;435:11–6.

Besiroglu H, Otunctemur A, Ozbek E. The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med 2015;12(6):1309–18.

Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V. Is erectile dysfunction predictive of peripheral vascular disease? Aging Male 2003;6(4):217–21.

Belew D, Klaassen Z, Lewis RW. Intracavernosal injection for the diagnosis, evaluation, and treatment of erectile dysfunction: a review. Sex Med Rev 2015;3(1):11–23.

DeRogatis LR, Burnett AL. The epidemiology of sexual dysfunctions. J Sex Med 2008;5(2):289–300.

Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96(12B):85M–93M.

Hsieh C-H, Liu S-P, Hsu G-L, Chen H-S, Molodysky E, Chen Y-H, et al. Advances in understanding of mammalian penile evolution, human penile anatomy and human erection physiology: clinical implications for physicians and surgeons. Med Sci Monit 2012;18(7):RA118–25.

Hsu GL. Hypothesis of human penile anatomy, erection hemodynamics and their clinical applications. Asia J Androl 2006;8(2):225–34.

DeFina LF, Radford NB, Leonard D, Wilson RK, Cooper TC, Clark SM, et al. Traditional signs and symptoms commonly attributed to hypogonadism do not correlate with testosterone levels: the Cooper Center Longitudinal Study Experience. J Investig Med 2020;68(2):278–82.

Kapoor D, Clarke S, Channer K, Jones TH. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Int J Androl 2007;30(6):500–7.

Kalinchenko SY, Kozlov GI, Gontcharov NP, Katsiya GV. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male 2003;6(2):94–9.

Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 2007;52(1):54–70.

Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, et al. Testosterone restores diabetes‐induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006;3(2):253–64.

Downloads

Download data is not yet available.
Published
2020-12-31
How to Cite
1.
Hassan J, Rehman S, Shah I, Shereen M, Abideen Z, Salman H. Testosterone in patients of erectile dysfunction with and without diabetes mellitus type 2. PJP [Internet]. 31Dec.2020 [cited 11Apr.2021];16(4):3-. Available from: http://pjp.pps.org.pk/index.php/PJP/article/view/1298